Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

N/ANon-phased studies

4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials

Showing 4 of 4

completednot_applicable

Evaluation of the FluidVision Accommodating Intraocular Lens (AIOL) With an Improved Injector System

NCT02418871

Clinical Trials (4)

Showing 4 of 4 trials

NCT03508778Not Applicable

Clinical Evaluation of the FluidVision Accommodation Intraocular Lens (AIOL)

Completed

NCT02049567Not Applicable

Clinical Evaluation of the FluidVision Accommodating Intraocular Lens (AIOL)

Completed

NCT03925545Not Applicable

VisiOn Restoration With FluidVisION Accommodating Intraocular Lens (AIOL)

Completed

NCT02418871Not Applicable

Evaluation of the FluidVision Accommodating Intraocular Lens (AIOL) With an Improved Injector System

Completed

All 4 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 4